[1] 李晖,晏春丽,朱姝娟,等.不孕症患者发生焦虑抑郁的相关因素研究进展[J].护理学报,2009,16(10B):4-6.[2] 陈骞,孙海翔,胡娅莉,等.子宫内膜厚度对体外受精-胚胎移植治疗结局的影响[J].生殖与避孕,2008,10(12):730-733.[3] Ardaems Y, Gougeon A, Ldebvre C, et al. Contribution of ovarian and uterine color Doppler in medically assisted reproduction technique(ART)[J]. Gynecol Obstet Fertil, 2002,30(9):663-672.[4] Momeni M, Rahbar M H, Kovanci E. A meta-analysis of the relationship between endometrial thickness and outcome of in vitro fertilization cycles[J]. J Hum Reprod Sci, 2011,4(3):130-137.[5] Zhang X, Chen C H, Confino E, et al. Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization-embryo transfer[J]. Fertil Steril, 2005,83(2):336-340.[6] Weckstein L N, Jacobson A, Galen D, et al. Low-dose aspirin for oocyte donation Recipients with thin endometrium: prospective, randomized study[J]. Fertil Steril, 1997,68(5):927-930.[7] Basir G S, O W S, So W W, et al. Evaluation of cycle-to-cycle variation of endometrial responsiveness using transvaginal sonography in women undergoing assisted reproduction[J]. Ultrasound Obstet Gynecol, 2002,19(5):484-489.[8] Dain L, Bider D, Levron J, et al. Thin endometrium in donor oocyte recipients: enigma or obstacle for implantation[J]. Fertil Steril, 2013,100(5):1289-1295.[9] Järvelä I Y, Sladkevicius P, Kelly S, et al. Evaluation of endometrial receptivity during in-vitro fertilization using three-dimensional power Doppler ultrasound[J]. Ultrasound Obstet Gynecol, 2005,26(7):765-769.[10] Lebovitz O, Orvieto R. Treating patients with "thin" endometrium-an ongoing challenge[J]. Gynecol Endocrinol, 2014,30(6):409-414.[11] 刘萍.阿司匹林对多囊卵巢综合征患者子宫内膜容受性及妊娠结局的影响[J].中国煤炭工业医学杂志,2012,15(10):1521-1522.[12] Satirapod C, Wingprawat S, Jultanmas R, et al. Effect of estradiol valerate on endometrium thickness during clomiphene citrate-stimulated ovulation[J]. J Obstet Gynaecol Res, 2014,40(1):96-101.[13] Myers E M, Hurst B S. Comprehensive management of severe Asherman syndrome and amenorrhea[J]. Fertil Steril, 2012,97(1):160-164.[14] Lidegaard ф, Edstrm B, Kreiner S. Oral contraceptives and venous thromboembolism: a five-year national case-control study[J]. Contraception, 2002,65(3):187-196.[15] 徐洪水,黄湘,虞金宝.覆盆子的药理和临床应用进展[J].实用中西医结合临床,2003,3(6):58-59.[16] 黄婉,杨耀芳.女贞子及其有效成分的药理及临床研究进展[J].现代中西医结合杂志,2003,12(7):772-774.[17] 黄秀兰,周亚伟,王伟.淫羊藿黄酮类化合物药理研究进展[J].中成药,2005,27(6):719-721.[18] 朱瑞清,李志忠,周建,等.淫羊藿苷及其拟代谢物的雌激素样作用研究[J].中医药学报,2012,40(3):15-20.[19] 赵丕文,王大伟,王玲巧,等.用小鼠子宫增重法筛选淫羊藿等10种中药雌激素样作用的实验研究[J].北京中医药大学学报,2003,29(10):686-689.[20] 马宝兰,秦绪花,史载祥.西洋参临床药理研究进展(2004-2010)[J].江西中医学院学报,2011,23(5):88-92.[21] 吴冬梅,宋岩峰.人参皂苷治疗妇产科疾病研究进展[J].中国妇幼健康研究,2007,18(3):240-242.[22] 林耀堂.补肾中药复方对雌性去势大鼠脑皮质和海马区神经细胞的影响 附资癸胶囊治疗围绝经期相关症状的临床初步观察.四川:成都中医药大学中医妇科系,2001.[23] 姜向坤.补肾复方对去势雌性大鼠骨影响的实验研究.四川:成都中医药大学中医妇科系,2004. |